documents: FDA-2017-D-5625-0011
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2017-D-5625-0011 | FDA | FDA-2017-D-5625 | Recommendations for Dual 510(k) and Clinical Laboratory Improvement Amendments Waiver by Application Studies; Draft Guidance for Industry and Food and Drug Administration Staff; Availability | Notice | Notice of Availability | 2018-11-29T05:00:00Z | 2018 | 11 | 2018-11-29T05:00:00Z | 2019-02-28T04:59:59Z | 2024-11-12T22:50:46Z | 2018-25960 | 1 | 0 | 090000648390c0b9 |
Links from other tables
- 1 row from regs_document_id in fr_regs_crossref